Full Product Name
ACSF3 Antibody (Center)
Product Synonym Names
Acyl-CoA synthetase family member 3; mitochondrial; 621-; ACSF3
Product Gene Name
anti-ACSF3 antibody
[Similar Products]
Antibody/Peptide Pairs
ACSF3 peptide (MBS9225845) is used for blocking the activity of ACSF3 antibody (MBS9203084)
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Immunogen Sequence Positions
413-442
3D Structure
ModBase 3D Structure for Q4G176
Species Reactivity
Human, mouse
Specificity
This ACSF3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 413-442 amino acids from the Central region of human ACSF3.
Purity/Purification
Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)
Form/Format
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
Concentration
Vial Concentration: 0.5 (lot specific)
Antigen Type
Synthetic Peptide
Preparation and Storage
Maintain refrigerated at 2-8 degree C for up to 6 months. For long term storage store at -20 degree C in small aliquots to prevent freeze-thaw cycles.
Other Notes
Small volumes of anti-ACSF3 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Product Categories/Family for anti-ACSF3 antibody
Cardiovascular; Signal Transduction
Applications Tested/Suitable for anti-ACSF3 antibody
Western Blot (WB), ELISA (EIA), Immunohistochemistry (IHC)
Application Notes for anti-ACSF3 antibody
WB~~1:1000
Western Blot (WB) of anti-ACSF3 antibody
ACSF3 Antibody (Center) western blot analysis in mouse heart tissue lysates (15ug/lane).This demonstrates the ACSF3 antibody detected ACSF3 protein (arrow).

Immunohistochemistry (IHC) of anti-ACSF3 antibody
ACSF3 antibody (Center) immunohistochemistry analysis in formalin fixed and paraffin embedded human tonsils tissue followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the ACSF3 antibody (Center) for immunohistochemistry. Clinical relevance has not been evaluated.

NCBI/Uniprot data below describe general gene information for ACSF3. It may not necessarily be applicable to this product.
NCBI Accession #
NP_001120686.1
[Other Products]
NCBI Related Accession #
Human, mouseNP_001230208.1; NP_777577.2[Other Products]
NCBI GenBank Nucleotide #
NM_001127214.3
[Other Products]
UniProt Primary Accession #
Q4G176
[Other Products]
UniProt Secondary Accession #
Q6INA0; Q8N2F7; A8K4J8; C9JQL6[Other Products]
UniProt Related Accession #
Q4G176[Other Products]
NCBI Official Full Name
acyl-CoA synthetase family member 3, mitochondrial isoform 1
NCBI Official Synonym Full Names
acyl-CoA synthetase family member 3
NCBI Official Symbol
ACSF3??[Similar Products]
NCBI Protein Information
acyl-CoA synthetase family member 3, mitochondrial
UniProt Protein Name
Acyl-CoA synthetase family member 3, mitochondrial
Protein Family
Acyl-CoA synthetase family
UniProt Gene Name
ACSF3??[Similar Products]
UniProt Entry Name
ACSF3_HUMAN
NCBI Summary for ACSF3
This gene encodes a member of the acyl-CoA synthetase family of enzymes that activate fatty acids by catalyzing the formation of a thioester linkage between fatty acids and coenzyme A. The encoded protein is localized to mitochondria, has high specificity for malonate and methylmalonate and possesses malonyl-CoA synthetase activity. Mutations in this gene are a cause of combined malonic and methylmalonic aciduria. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Sep 2013]
UniProt Comments for ACSF3
ACSF3: Catalyzes the initial reaction in intramitochondrial fatty acid synthesis, by activating malonate and methylmalonate, but not acetate, into their respective CoA thioester. May have some preference toward very-long-chain substrates. Defects in ACSF3 are the cause of combined malonic and methylmalonic aciduria (CMAMMA). A metabolic disease characterized by malonic and methylmalonic aciduria, with urinary excretion of much larger amounts of methylmalonic acid than malonic acid, in the presence of normal malonyl-CoA decarboxylase activity. Clinical features include coma, ketoacidosis, hypoglycemia, failure to thrive, microcephaly, dystonia, axial hypotonia and/or developmental delay, and neurologic manifestations including seizures, psychiatric disease and/or cognitive decline. Belongs to the ATP-dependent AMP-binding enzyme family.
Protein type: Ligase; EC 6.2.1.-; EC 6.-.-.-
Chromosomal Location of Human Ortholog: 16q24.3
Cellular Component: mitochondrion
Molecular Function: acid-thiol ligase activity; ATP binding
Biological Process: fatty acid metabolic process; fatty acid biosynthetic process
Disease: Combined Malonic And Methylmalonic Aciduria
Research Articles on ACSF3
1. ACSF3 was significantly upregulated, and was involved in fatty acid and lipid metabolism and accelerated liver injury in alcoholic liver disease.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.